Skip to main content
OpenTrials
Completed

NCT Number: NCT04805476

Prophylactic Use of Noninvasive Ventilation in the Postoperative Period of Bariatric Surgery

Comorbidities associated with severe obesity determine an important public health problem. Few methods are considered potentially effective for the treatment of severe obesity and the clinical relevance of bariatric surgery is growing, as well as the number of procedures performed. The insertion of the physiotherapist in the multiprofessional team responsible for performing the surgical procedure is essential from the preoperative screening and evaluation to the prevention and treatment of postoperative complications. Therefore, the physiopathological aspects involved with severe obesity, the technical aspects and risks of the surgical procedure, as well as the physiotherapeutic techniques that have scientific proof must be known by the physiotherapist responsible for the surgical follow-up of the patient. In this context, the use of non-invasive ventilation (NIV) in the postoperative period of bariatric surgery has ample therapeutic potential. The present research project aims to evaluate the immediate prophylactic use of NIV on the respiratory and functional recovery of the patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bariatric Surgery Candidate Body Weight Hypoventilation Nutrition Disorders Nutritional and Metabolic Diseases Obesity Obesity, Morbid Overnutrition Overweight Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Insufficiency Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory Ventilatory Failure

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

About this study

The study will be performed at the surgical center of the Hospital de Clínicas of Porto Alegre. After approval by the Research Ethics Committee, patients must sign the Term of Consent for inclusion in the study. A blinded investigator will record clinical, anthropometric, pulmonary function tests, and functional measures. Patients submitted to open bariatric surgery will be divided into two groups for the use of NIV: immediate post-extubation (IG) and non-intervention (standard group [GP]). Patients will be randomly assigned to the groups. All subjects will undergo general anesthesia and postoperative analgesia, using a standardized surgical team approach. Patients who present the contraindication criteria for the use of NIV will be excluded from the study.

After the surgical procedure and extubation, GP subjects will receive oxygen therapy through a nasal cannula with 4 to 6 L / min of oxygen according to the team routine and patient need. The subjects in the immediate intervention group (GI) will be extubated and placed in NIV the moment they enter the recovery room through a portable ventilator (Esprit ® or BiPAP Vision ®, Respironics) in face mask. The parameters will be adjusted as follows: FiO2 = 50%, positive expiratory pressure (EPAP, starting at 4-6 cmH2O and adjusting 1-2 cmH2O to avoid snoring, apnea, paradoxical breathing and desaturations) and adjusted inspiratory positive pressure (IPAP) to maintain a tidal volume of 400 to 500 ml, maintaining IPAP <15cmH2O17. Individuals will receive this ventilatory support for 1 hour. After this period the patients will be submitted to the same care of GP patients. Measurement of respiratory muscle strength and lung function will be recorded in Time 1 (in the preoperative period), Time 2 (at the time of entry of the recovery room) and Time 3 (1 hour after extubation, with withdrawal of the support ventilatory). Vital signs (heart rate, peripheral O2 Saturation and Blood Pressure) will also be recorded through the multi-parameter monitor (IntelliVue MP40).

The functional evaluation will be performed in the period of the initial data collection through the Functional Status Score for the ICU (FSS-ICU) and Functional Independence Measure (MIF). Patients will be monitored during the hospitalization period until hospital discharge and records of postoperative complications (radiological changes, infections and surgical anastomosis fistulas) will be recorded by blinded evaluator. The final evaluation will be done through the MIF, through telephone contact 1 month after the surgery.

During the study participation patients may present with discomfort, nausea, vomiting and / or pain related to the use of non-invasive ventilation and procedures performed to evaluate muscle strength, lung function and functionality. In a study with methodology and similar population, such risks / complications were not reported16, however, if they occur, the procedures will be immediately interrupted and patients will be assisted by the study researchers in order to preserve the patients and the reliability of the results.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients undergoing bariatric surgery

Exclusion criteria

  • Absolute or relative contraindications to the use of NIV

Treatment and study plan

Non invasive mechanical ventilation

Device

Prophylactic non invasive mechanical ventilation

GP

Device

GP subjects will receive oxygen therapy through a nasal cannula with 4 to 6 L / min of oxygen according to team routine and patient need.

Primary outcomes

  1. Forced Vital Capacity (FVC)

    Time frame: Preoperative

    Larger volume of air mobilized on an exhalation.

  2. Forced Vital Capacity (FVC)

    Time frame: 10 minutes after admission to the recovery room

    Larger volume of air mobilized on an exhalation.

  3. Forced Vital Capacity (FVC)

    Time frame: 1 hour after admission to the recovery room

    Larger volume of air mobilized on an exhalation.

  4. Forced expiratory volume in one second (FEV1)

    Time frame: Preoperative

    Volume of air exhaled in the first second during the FVC maneuver.

  5. Forced expiratory volume in one second (FEV1)

    Time frame: 10 minutes after admission to the recovery room

    Volume of air exhaled in the first second during the FVC maneuver.

  6. Forced expiratory volume in one second (FEV1)

    Time frame: 1 hour after admission to the recovery room

    Volume of air exhaled in the first second during the FVC maneuver.

  7. FEV1/FVC ratio

    Time frame: Preoperative

    Ratio between forced expiratory volume in the first second and vital capacity.

  8. FEV1/FVC ratio

    Time frame: 10 minutes after admission to the recovery room

    Ratio between forced expiratory volume in the first second and vital capacity.

  9. FEV1/FVC ratio

    Time frame: 1 hour after admission to the recovery room

    Ratio between forced expiratory volume in the first second and vital capacity.

  10. Peak expiratory flow (PEF)

    Time frame: Preoperative

    Maximum air flow during the FVC maneuver.

  11. Peak expiratory flow (PEF)

    Time frame: 10 minutes after admission to the recovery room

    Maximum air flow during the FVC maneuver.

  12. Peak expiratory flow (PEF)

    Time frame: 1 hour after admission to the recovery room

    Maximum air flow during the FVC maneuver.

Sponsors and collaborators

Lead sponsor

Hospital de Clinicas de Porto Alegre

Other

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Mar 18, 2021
Registry last updated
Mar 18, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.